On this episode Gil and Gregg welcome Mike Banville, CEO of Alzpath, to discuss the critical need for early and accessible Alzheimer’s diagnostics. Alzpath is pioneering a blood-based biomarker test for Alzheimer’s that has the potential to transform how—and when—this devastating disease is detected. This episode is a must-listen for healthcare professionals, caregivers, policymakers, and anyone interested in the intersection of biotechnology, aging, and public health. Learn why Alzpath’s technology could soon be as routine as checking cholesterol—and why that could change millions of lives.

To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”.

Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen